Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma
Authors:
Open Access
- 21 November 2023
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 29 (43) , 5804-5817
Abstract
Surgical resection is the primary treatment for hepatocellular carcinoma (HCC). However, studies indicate that nearly 70% of patients experience HCC recurrence within five years following hepatectomy. The earlier the recurrence, the worse the prognosis. Current studies on postoperative recurrence primarily rely on posto perative pathology and patient clinical data, which are lagging. Hence, develop ing a new pre-operative prediction model for postoperative recurrence is crucial for guiding individualized treatment of HCC patients and enhancing their pro gnosis. To identify key variables in pre-operative clinical and imaging data using ma chine learning algorithms to construct multiple risk prediction models for early postoperative recurrence of HCC. The demographic and clinical data of 371 HCC patients were collected for this retrospective study. These data were randomly divided into training and test sets at a ratio of 8:2. The training set was analyzed, and key feature variables with predictive value for early HCC recurrence were selected to construct six different machine learning prediction models. Each model was evaluated, and the best-performing model was selected for interpreting the importance of each variable. Finally, an online calculator based on the model was generated for daily clinical practice. Following machine learning analysis, eight key feature variables (age, intratumoral arteries, alpha-fetoprotein, pre-operative blood glucose, number of tumors, glucose-to-lymphocyte ratio, liver cirrhosis, and pre-operative platelets) were selected to construct six different prediction models. The XGBoost model outperformed other models, with the area under the receiver operating characteristic curve in the training, validation, and test datasets being 0.993 (95% confidence interval: 0.982-1.000), 0.734 (0.601-0.867), and 0.706 (0.585-0.827), respectively. Calibration curve and decision curve analysis indicated that the XGBoost model also had good predictive performance and clinical application value. The XGBoost model exhibits superior performance and is a reliable tool for predicting early postoperative HCC recurrence. This model may guide surgical strategies and postoperative individualized medicine.Keywords
This publication has 31 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After SurgeryClinical Gastroenterology and Hepatology, 2018
- Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic OpportunitiesOxidative Medicine and Cellular Longevity, 2018
- Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancerComputational and Structural Biotechnology Journal, 2018
- Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resectionScientific Reports, 2017
- Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group StudyChemotherapy, 2016
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statementBMJ, 2014
- Gamma-Glutamyl Transpeptidase2014
- Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular CarcinomaAmerican Journal of Gastroenterology, 2013
- The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cellsMolecular Cancer, 2009